Clinical Trial Update: A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients [Phase 2]

View source ↗

Summary

A Phase IIa trial evaluating whether interferon gamma-1b can safely elevate frataxin levels in Friedreich's ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: Azienda Policlinico Umberto I | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED